phosphoprotein Enriched in Astrocytes 15 (PEA15) (C-Term) Peptid
PEA15
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN981572
Kurzübersicht für phosphoprotein Enriched in Astrocytes 15 (PEA15) (C-Term) Peptid (ABIN981572)
Target
PEA15
(phosphoprotein Enriched in Astrocytes 15 (PEA15))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequenz
- DYRTRVLKIS EEDELDTKLT RIPSAKKYKD IIRQPSEEEI IKLAPPPKKA
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-PEA15 Antibody(ARP58923_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PEA15 (phosphoprotein Enriched in Astrocytes 15 (PEA15))
-
Hintergrund
-
PEA15 is a death effector domain (DED)-containing protein predominantly expressed in the central nervous system, particularly in astrocytes.
Alias Symbols: HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED
Protein Interaction Partner: AKT1,MAPK3,RPS6KA3,ABCD4,AKD1,AKT1,CAMK2G,CASP8,FADD,HTRA2,L1CAM,LUC7L2,MAPK1,MAPK3,PANK4,PLD1,PLD2,PRKCA,RPS6KA3,ABCD4,CASP8,FADD,Gm899,L1CAM,LUC7L2,MAPK1,MAPK3,PLD1,PLD2,RPS6KA3
Protein Size: 130 -
Molekulargewicht
- 15 kDa
-
Gen-ID
- 8682
-
NCBI Accession
- NM_003768, NP_003759
-
UniProt
- Q5U318
Target
-
Sie sind hier:
